Cohort Study | Ibrutinib is associated with increased cardiovascular events and major bleeding in older CLL patients

Ibrutinib Is Associated With Increased Cardiovascular Events and Major Bleeding in Older CLL Patients – JACC: CardioOncology

Commentary on Twitter

#Ibrutinib was associated with an increased risk of stroke, #AFib and bleeding, especially in older patients. The risk of major bleeding is higher than previously reported. https://t.co/dhP7Kwogdt#JACCCardioOnc #CardioOnc #geriheme #lymsm #leusm #CLL @AkivaDiamond @paolocaimiMD pic.twitter.com/MvzCh1i6LU

— JACC Journals (@JACCJournals) May 4, 2023